Chaperone-mediated autophagy: roles in neuroprotection

Neuroscience Bulletin

Volumn 31, Issue 4, 2015, Pages 452-458

  Cai, Zhibiao ^a   Zeng, Weijun ^a   Tao, Kai ^a   Zhen, E ^a   Wang, Bao ^a   Yang, Qian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

cellular homeostasis; chaperone mediated autophagy; neurodegenerative disease; neuronal death; neuroprotection

Indexed keywords

HEAT SHOCK COGNATE PROTEIN 70; HYDROLASE; LYSOSOMEASSOCIATED MEMBRANE PROTEIN TYPE 2A; MEMBRANE PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG; CHAPERONE;

ACETYLATION; ALZHEIMER DISEASE; CELL FUNCTION; CHAPERONE-MEDIATED AUTOPHAGY; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; LIPID COMPOSITION; LYSOSOME; LYSOSOME MEMBRANE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN DEGRADATION; REVIEW; ANIMAL; AUTOPHAGY; METABOLISM; NERVE CELL; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; AUTOPHAGY; HUMANS; HUNTINGTON DISEASE; LYSOSOMES; MOLECULAR CHAPERONES; NEURONS; PARKINSON DISEASE;

EID: 84938989356     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-015-1540-x     Document Type: Review

References (67)

1. Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Hematology Am Soc Hematol Educ Program 2006: 1–12, 505–506.
2. Knecht E, Aguado C, Carcel J, Esteban I, Esteve JM, Ghislat G, et al. Intracellular protein degradation in mammalian cells: recent developments. Cell Mol Life Sci 2009, 66: 2427–2443.
3. Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443: 780–786.
4. Roth DM, Balch WE. Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol 2011, 23: 126–134.
5. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008, 451: 1069–1075.
6. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 2009, 78: 477–513.
7. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 2003, 426: 895–899.
8. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009, 43: 67–93.
9. Grant BD, Donaldson JG. Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 2009, 10: 597–608.
10. Nikoletopoulou V, Papandreou ME, Tavernarakis N. Autophagy in the physiology and pathology of the central nervous system. Cell Death Differ 2015, 22: 398–407.
11. Rami A. Review: autophagy in neurodegeneration: fi refi ghter and/or incendiarist? Neuropathol Appl Neurobiol 2009, 35: 449–461.
12. Ahlberg J, Glaumann H. Uptake—microautophagy—and degradation of exogenous proteins by isolated rat liver lysosomes. Effects of pH, ATP, and inhibitors of proteolysis. Exp Mol Pathol 1985, 42: 78–88.
13. Arias E, Cuervo AM. Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 2011, 23: 184–189.
14. Dice JF. Chaperone-mediated autophagy. Autophagy 2007, 3: 295–299.
15. Cuervo AM. Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab 2010, 21: 142–150.
16. Dice JF. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 1990, 15: 305–309.
17. Kaushik S, Cuervo AM. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 2012, 22: 407–417.
18. Fuertes G, Martin De Llano JJ, Villarroya A, Rivett AJ, Knecht E. Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confl uent conditions. Biochem J 2003, 375: 75–86.
19. Massey AC, Kaushik S, Sovak G, Kiffin R, Cuervo AM. Consequences of the selective blockage of chaperonemediated autophagy. Proc Natl Acad Sci U S A 2006, 103: 5805–5810.
20. Cuervo AM, Hu W, Lim B, Dice JF. IkappaB is a substrate for a selective pathway of lysosomal proteolysis. Mol Biol Cell 1998, 9: 1995–2010.
21. Cuervo AM, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res 2014, 24: 92–104.
22. Chiang HL, Dice JF. Peptide sequences that target proteins for enhanced degradation during serum withdrawal. J Biol Chem 1988, 263: 6797–6805.
23. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, et al. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 2011, 42: 719–730.
24. Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A, et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol 2009, 187: 1083–1099.
25. Agarraberes FA, Dice JF. A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J Cell Sci 2001, 114: 2491–2499.
26. Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 2008, 28: 5747–5763.
27. Shin Y, Klucken J, Patterson C, Hyman BT, McLean PJ. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem 2005, 280: 23727–23734.
28. Wing SS, Chiang HL, Goldberg AL, Dice JF. Proteins containing peptide sequences related to Lys-Phe-Glu-Arg- Gln are selectively depleted in liver and heart, but not skeletal muscle, of fasted rats. Biochem J 1991, 275 (Pt 1): 165–169.
29. Quintavalle C, DiCostanzo S, Zanca C, Tasset I, Fraldi A, Incoronato M, et al. Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells. J Cell Physiol 2014, 229: 1359–1368.
30. Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, et al. Regulation of neuronal survival factor MEF2D by chaperonemediated autophagy. Science 2009, 323: 124–127.
31. Cuervo AM, Dice JF. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996, 273: 501–503.
32. Cuervo AM, Mann L, Bonten EJ, d’Azzo A, Dice JF. Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor. EMBO J 2003, 22: 47–59.
33. Kaushik S, Massey AC, Cuervo AM. Lysosome membrane lipid microdomains: novel regulators of chaperone-mediated autophagy. EMBO J 2006, 25: 3921–3933.
34. Bandyopadhyay U, Sridhar S, Kaushik S, Kiffin R, Cuervo AM. Identification of regulators of chaperone-mediated autophagy. Mol Cell 2010, 39: 535–547.
35. Cuervo AM, Dice JF, Knecht E. A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem 1997, 272: 5606–5615.
36. Agarraberes FA, Terlecky SR, Dice JF. An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation. J Cell Biol 1997, 137: 825–834.
37. Cuervo AM, Knecht E, Terlecky SR, Dice JF. Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol 1995, 269: C1200–1208.
38. Kon M, Kiffin R, Koga H, Chapochnick J, Macian F, Varticovski L, et al. Chaperone-mediated autophagy is required for tumor growth. Sci Transl Med 2011, 3: 109ra117.
39. Kiffin R, Christian C, Knecht E, Cuervo AM. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004, 15: 4829–4840.
40. Gao L, She H, Li W, Zeng J, Zhu J, Jones DP, et al. Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease. Antioxid Redox Signal 2014, 20: 2936–2948.
41. Cuervo AM, Palmer A, Rivett AJ, Knecht E. Degradation of proteasomes by lysosomes in rat liver. Eur J Biochem 1995, 227: 792–800.
42. Dohi E, Tanaka S, Seki T, Miyagi T, Hide I, Takahashi T, et al. Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival. Neurochem Int 2012, 60: 431–442.
43. Ferreira JV, Fofo H, Bejarano E, Bento CF, Ramalho JS, Girao H, et al. STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy. Autophagy 2013, 9: 1349–1366.
44. Franch HA, Sooparb S, Du J, Brown NS. A mechanism regulating proteolysis of specifi c proteins during renal tubular cell growth. J Biol Chem 2001, 276: 19126–19131.
45. Zhou D, Li P, Lin Y, Lott JM, Hislop AD, Canaday DH, et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005, 22: 571–581.
46. Dengjel J, Schoor O, Fischer R, Reich M, Kraus M, Muller M, et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A 2005, 102: 7922–7927.
47. Deretic V. Links between autophagy, innate immunity, inflammation and Crohn's disease. Dig Dis 2009, 27: 246–251.
48. Wong E, Cuervo AM. Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb Perspect Biol 2010, 2: a006734.
49. Park C, Cuervo AM. Selective autophagy: talking with the UPS. Cell Biochem Biophys 2013, 67: 3–13.
50. Kaushik S, Massey AC, Mizushima N, Cuervo AM. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell 2008, 19: 2179–2192.
51. Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiol Dis 2009, 35: 385–398.
52. Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 2010, 67: 1464–1472.
53. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5: 525–535.
54. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperonemediated autophagy. Science 2004, 305: 1292–1295.
55. Yang Q, Mao Z. The complexity in regulation of MEF2D by chaperone-mediated autophagy. Autophagy 2009, 5: 1073–1074.
56. Orenstein SJ, Kuo SH, Tasset I, Arias E, Koga H, Fernandez-Carasa I, et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 2013, 16: 394–406.
57. Kabuta T, Furuta A, Aoki S, Furuta K, Wada K. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J Biol Chem 2008, 283: 23731–23738.
58. Kabuta T, Wada K. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Autophagy 2008, 4: 827–829.
59. Qi L, Zhang XD. Role of chaperone-mediated autophagy in degrading Huntington's disease-associated huntingtin protein. Acta Biochim Biophys Sin (Shanghai) 2014, 46: 83–91.
60. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001, 24: 1121–1159.
61. Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow EM, et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 2009, 18: 4153–4170.
62. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci 2007, 30: 575–621.
63. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003, 361: 1642–1644.
64. Qin ZH, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 2003, 12: 3231–3244.
65. Koga H, Martinez-Vicente M, Arias E, Kaushik S, Sulzer D, Cuervo AM. Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease. J Neurosci 2011, 31: 18492–18505.
66. Qi L, Zhang XD, Wu JC, Lin F, Wang J, DiFiglia M, et al. The role of chaperone-mediated autophagy in huntingtin degradation. PLoS One 2012, 7: e46834.
67. Anguiano J, Garner TP, Mahalingam M, Das BC, Gavathiotis E, Cuervo AM. Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat Chem Biol 2013, 9: 374–382.